Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome.
about
Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factorsLiver diseases in pregnancy: diseases unique to pregnancyExpression of lymphatic vascular endothelial hyaluronan receptor-1 (LYVE-1) in the human placentaPathophysiology of placentation abnormalities in pregnancy-induced hypertensionThe placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsiaTrophoblast 'pseudo-tumorigenesis': significance and contributory factorsPre-eclampsia: its pathogenesis and pathophysiolgyPlacental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentCombined Screening for Early Detection of Pre-EclampsiaTherapeutic potential of microRNA: a new target to treat intrahepatic portal hypertension?Innate immunity, decidual cells, and preeclampsiaAdvances in understanding and treating liver diseases during pregnancy: A reviewMurine pregnancy-specific glycoprotein 23 induces the proangiogenic factors transforming-growth factor beta 1 and vascular endothelial growth factor a in cell types involved in vascular remodeling in pregnancyExcess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsiaReversal of gene dysregulation in cultured cytotrophoblasts reveals possible causes of preeclampsia.Confocal laser scanning microscope study of cytokeratin immunofluorescence differences between villous and extravillous trophoblast: cytokeratin downregulation in pre-eclampsia.Suppression of extravillous trophoblast vascular endothelial growth factor expression and uterine spiral artery invasion by estrogen during early baboon pregnancyThe genetic aspects of pre-eclampsia: achievements and limitations.Thrombocytopenia in the parturient.Advances in understanding of pathogenesis of aHUS and HELLP.C5a enhances dysregulated inflammatory and angiogenic responses to malaria in vitro: potential implications for placental malaria.Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia.Periodic assessment of plasma sFlt-1 and PlGF concentrations and its association with placental morphometry in gestational hypertension (GH) - a prospective follow-up studyAbnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies.The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.Local over-expression of VEGF-DΔNΔC in the uterine arteries of pregnant sheep results in long-term changes in uterine artery contractility and angiogenesisMorphological and phenotypic analyses of the human placenta using whole mount immunofluorescence.No association between polymorphisms/haplotypes of the vascular endothelial growth factor gene and preeclampsia.Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications.Deciphering mechanisms controlling placental artery endothelial cell migration stimulated by vascular endothelial growth factor.Smoking in preeclamptic women is associated with higher birthweight for gestational age and lower soluble fms-like tyrosine kinase-1 levels: a nested case control studyAngiogenesis and chronic kidney disease.Alternate processing of Flt1 transcripts is directed by conserved cis-elements within an intronic region of FLT1 that reciprocally regulates splicing and polyadenylation.Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infectionEffects of maternal smoking on the placental expression of genes related to angiogenesis and apoptosis during the first trimesterPlasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.Differential expression of Vegfr-2 and its soluble form in preeclampsiaPrematurely elevating estradiol in early baboon pregnancy suppresses uterine artery remodeling and expression of extravillous placental vascular endothelial growth factor and α1β1 and α5β1 integrinsSera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assayPregnancy-induced hypertension and preeclampsia: levels of angiogenic factors in malaysian women
P2860
Q24303560-8D81E898-3B69-4DC2-8C24-DC8604D63249Q24596588-E8BEFC66-0A4C-43B6-8AFA-E9D5304632DCQ24623474-0995E6BB-82E7-4B79-978D-5137D3C25040Q24649934-8007A600-AFE2-4323-85FC-711E110A0143Q24795491-1A8DFDB2-6BA1-4322-9DBF-56620D8E79CCQ24798593-B80E0557-77D2-4375-BC34-27D8AEDBDE47Q26746841-11806494-AB7E-468D-8286-22D88EFA09D9Q26766128-8A8516E3-1C47-4622-9E2C-4D8459D29772Q26801503-CF05C87B-03FE-4B45-ACB1-090B1A554C9BQ26829662-ECA34202-25EA-44FA-BF93-4F47439F45BCQ27014127-4CEFA348-296A-42C5-A926-2B245C5D33E9Q28080792-0AE7C1C9-E73F-4834-885E-0F509466A83FQ28509861-3E82A38E-FEE5-4E47-BF8B-B4684FF53C05Q29615916-4B146016-FC8A-4D54-98EB-5442D742B7EEQ30576991-5005B003-D0C1-4C63-8F1A-316A72F75D5EQ33205370-EED0E733-645C-477A-A655-3A45578C22B0Q33345135-62420E90-7526-4093-A46B-3838EF4F86FFQ33345506-68AF8D64-D71C-4DC1-A771-5A4487C53210Q33359736-BD2D5608-A0E1-4FAE-929D-A752E6F54E64Q33380684-A15C7534-AF94-47F3-94A9-0168AB27E58BQ33420846-E78110BD-EA89-477C-887A-F1F80300506DQ33438425-0AC95B4B-A267-4AEF-A319-84E25C044465Q33709631-D8E79ECE-15E2-4EB1-97E7-1DE54E93C607Q33725645-FD010A6E-E7CD-4D07-BB34-ED6E871A395BQ33755648-83C858AE-3E34-47A6-9EB1-637792E15CD8Q33825498-00774729-4637-4107-B043-39DF783BC866Q33826174-1C2F2BC7-6323-4944-B4E6-E345950EDD85Q33901546-FE611486-975C-4385-92A5-EAD261A4201BQ33976312-96975791-6996-4455-B7C2-5E4024C3A6B3Q33993849-4394032D-83CA-4162-8AEF-6FD7D6CCE012Q34072122-9DD74336-0187-47F3-A49E-DD2F43F77C01Q34075013-287E1906-674F-4D5B-9CE9-CC9005E25657Q34080032-F5123B00-F5E5-473D-91D4-2369B2DB5DEEQ34086932-4B978963-11FD-4362-A38F-DD0C6BDDA7F9Q34105410-93254A8D-1671-4ADF-A56C-66807C52C248Q34119026-91E37B47-A889-40B1-952C-D72467F31580Q34201006-1C85F629-F223-488C-A0F8-D53EF58EEE77Q34229262-AC4C490E-FF19-40C4-B024-511DD736CD31Q34254466-DAC6DDFD-B5C4-4C3A-9AE7-54E177208C76Q34255236-14CC75D8-450E-433F-9630-097361F153A4
P2860
Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Vascular endothelial growth fa ...... s, and low platelets syndrome.
@ast
Vascular endothelial growth fa ...... s, and low platelets syndrome.
@en
type
label
Vascular endothelial growth fa ...... s, and low platelets syndrome.
@ast
Vascular endothelial growth fa ...... s, and low platelets syndrome.
@en
prefLabel
Vascular endothelial growth fa ...... s, and low platelets syndrome.
@ast
Vascular endothelial growth fa ...... s, and low platelets syndrome.
@en
P2093
P2860
P1476
Vascular endothelial growth fa ...... s, and low platelets syndrome.
@en
P2093
Caroline Damsky
Jean Perry
Kirstin Woo
Mary Janatpour
Michael McMaster
Susan J Fisher
Terhi Karpanen
P2860
P304
P356
10.1016/S0002-9440(10)62567-9
P407
P50
P577
2002-04-01T00:00:00Z